Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Janssen, Paul W.A."'
Autor:
Willemsen, Laura M. *, Vlot, Eline A., Janssen, Paul W.A., Visser, Claire D., Zheng, Kai, Kelder, Johannes C., Noordzij, Peter G., van den Dool, Erik‐Jan, Klein, Patrick, Hackeng, Christian M., ten Berg, Jurrien M.
Publikováno v:
In Research and Practice in Thrombosis and Haemostasis December 2021 5(8)
Autor:
Leunissen, Tesse C., Janssen, Paul W.A., ten Berg, Jurriën M., Moll, Frans L., Korporaal, Suzanne J.A., de Borst, Gert Jan, Pasterkamp, Gerard, Urbanus, Rolf T.
Publikováno v:
In Vascular Pharmacology February 2016 77:19-27
Triple Therapy for Atrial Fibrillation and Percutaneous Coronary Intervention: A Contemporary Review
Autor:
Dewilde, Willem J.M., Janssen, Paul W.A., Verheugt, Freek W.A., Storey, Robert F., Adriaenssens, Tom, Hansen, Morten L., Lamberts, Morten, ten Berg, Jurriën M.
Publikováno v:
In Journal of the American College of Cardiology 23 September 2014 64(12):1270-1280
Publikováno v:
In Blood Reviews May 2014 28(3):109-121
Autor:
Willemsen, Laura M., Janssen, Paul W.A., Hackeng, Chris M., Kelder, Johannes C., Tijssen, Jan G.P., van Straten, Albert H.M., Soliman-Hamad, Mohammed A., Deneer, Vera H.M., Daeter, Edgar J., Sonker, Uday, Klein, Patrick, ten Berg, Jurriën M., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
American Heart Journal, 220, 237. Mosby Inc.
American heart journal, 220, 237-245. Mosby Inc.
American heart journal, 220, 237-245. Mosby Inc.
Rationale An estimated 15% of saphenous vein grafts (SVGs) occlude in the first year after coronary artery bypass grafting (CABG) despite aspirin therapy. Graft occlusion can result in symptoms, myocardial infarction, and death. SVG occlusion is prim
Autor:
Sandner, Sigrid, Redfors, Björn, Angiolillo, Dominick J., Audisio, Katia, Fremes, Stephen E., Janssen, Paul W.A., Kulik, Alexander, Mehran, Roxana, Peper, Joyce, Ruel, Marc, Saw, Jacqueline, Soletti, Giovanni Jr, Starovoytov, Andrew, ten Berg, Jurrien M., Willemsen, Laura M., Zhao, Qiang, Zhu, Yunpeng, Gaudino, Mario
Publikováno v:
JAMA: Journal of the American Medical Association; 8/9/2022, Vol. 328 Issue 6, p554-562, 9p
Autor:
Janssen, Paul W.A., Bergmeijer, Thomas O., Vos, Gert Jan A., Kelder, Johannes C., Qaderdan, Khalid, Godschalk, Thea C., Breet, Nicoline J., Deneer, Vera H.M., Hackeng, Christian M., ten Berg, Jurriën M., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
European Journal of Clinical Pharmacology, 75(9), 1201. Springer
European Journal of Clinical Pharmacology, 75(9), 1201. Springer Verlag
European Journal of Clinical Pharmacology, 75(9), 1201. Springer Verlag
PURPOSE: The POPular Risk Score was developed for the selective intensification of P2Y 12 inhibitor treatment with prasugrel instead of clopidogrel in patients undergoing non-urgent percutaneous coronary intervention (PCI) with stent implantation. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d211269ebfd09dbd8272d71fe64ec7b
https://dspace.library.uu.nl/handle/1874/391926
https://dspace.library.uu.nl/handle/1874/391926
Publikováno v:
In JACC: Cardiovascular Interventions 9 March 2020 13(5):631-633
Autor:
Dewilde, Willem J.M., Janssen, Paul W.A., Verheugt, Freek W.A., Storey, Robert F., Adriaenssens, Tom, Hansen, Morten L., Lamberts, Morten, ten Berg, Jurriën M.
Publikováno v:
In Journal of the American College of Cardiology 10 February 2015 65(5):516-518
Incidence and Causes for Early Ticagrelor Discontinuation: A "Real-World" Dutch Registry Experience.
Autor:
Bergmeijer, Thomas O., Janssen, Paul W.a., van Oevelen, Mathijs, van Rooijen, Dymphie, Godschalk, Thea C., Kelder, Johannes C., Deneer, Vera H.M., Serebruany, Victor L., ten Berg, Jurriën M.
Publikováno v:
Cardiology; Nov2017, Vol. 138 Issue 3, p164-168, 5p, 2 Charts, 1 Graph